Case Studies
Strong DMC Management for Renal and Cardiac Studies
Everest delivered seamless DMC management and statistical support for two complex renal studies, ensuring smooth transitions, structured oversight, and consistent reporting.
View More
ISS/ISE and Regulatory Success for a GI Therapeutic
Everest helped a top-5 pharmaceutical company receive NDA approval for an Ulcerative Colitis treatment. Everest continues to have a longstanding, positive relationship with the client due to the success of this project.
View More
IRT Support for a Long-Term, Complex Rare Disease Study
Everest deployed its in-house IRT/RTSM technology, in addition to its expert team, to help the sponsor overcome several supply and dosing management challenges during a global, open-label extension study.
View More
Long-Term FSP Partnership for Biostatistics and Programming
Everest continues to help a global pharmaceutical company scale its operations through a strong and longstanding partnership, providing both project-based work and FSP (Functional Service Provider) staff augmentation models.
Successful Data Management Rescue for Multiple Ophthalmology Studies
Everest quickly stepped in to restore data quality and to get four failing Phase II/III clinical trials back on track.
View More
Top-tier Biometrics Provider for a Pediatric Neurodegenerative Study
Everest provided high-touch data management and biostatistics and programming support for a biotech company conducting its interventional study. A vulnerable pediatric population required strong data and safety surveillance.
Flexible Clinical Operations for a Rare Disease Biotech
Everest scouted more than 200 sites and onboarded more than 65 in this full-service study. The small biotech sponsor had a very small team and relied heavily on Everest to drive results.
View More
16,000-Patient, Global Respiratory Trial that was Findings Free
Everest provided biometrics and IWRS support to a large-scale, global Phase III trial spanning 26 countries. The FDA and EMA Inspection Reports had 0 inspection findings on the work performed by Everest.
View More
Successful Rescue of Two Full-Service Oncology Studies
Everest quickly took control of clinical operations for two oncology studies, stepping in for a much larger CRO. Everest has completed enrollment early for one study and is currently ahead of schedule for the second.
View More